Development of a Subunit Vaccine against Duck Hepatitis A Virus Serotype 3

In this study, we sought to develop a subunit vaccine against the increasingly prevalent Duck hepatitis A virus serotype 3 (DHAV-3). The VP1 protein of DHAV-3 and a truncated version containing the C-terminal region of VP1, termed VP1-C, were expressed recombinantly in Escherichia coli as vaccine an...

Descripción completa

Detalles Bibliográficos
Autores principales: Truong, Trang-Nhu, Cheng, Li-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028120/
https://www.ncbi.nlm.nih.gov/pubmed/35455272
http://dx.doi.org/10.3390/vaccines10040523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028120/
https://www.ncbi.nlm.nih.gov/pubmed/35455272
http://dx.doi.org/10.3390/vaccines10040523

Ejemplares similares